Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Gynecologic Oncology Physician in Duarte, CA
NPI: 1073730891Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get M.D. Thanh's Phone NumberMobile
Get M.D. Thanh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2026
PA State Medical License
2004 - 2008
American Board of Obstetrics and Gynecology
Gynecologic Oncology
American Board of Obstetrics and Gynecology
Obstetrics & Gynecology
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 2004
University of California (Irvine)
Fellowship • Gynecologic Oncology
2008 - 2012
Penn State Milton S Hershey Medical Center
Residency • Obstetrics and Gynecology
2004 - 2008
University of California, San Diego
BS • Biochemistry
1995 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 100 | 176 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 24 | 24 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 19 | 28 |
Authors: Scott Glaser, Stephen Lee, Yi-Jen Chen, Sushil Beriwal, Mark Wakabayashi, Arya Amini, Ernest Han
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2018-06-08
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.
Authors: Cai Roberts, Michelle Tran, Mary Pitruzzello, Wei Wen, Joana Loeza, Thanh Dellinger, Gil Mor, Carlotta Glackin
Publication Date: 2016-07-20
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, DRUG: Doxorubicin, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Irinotecan, DRUG: Leucovorin, PROCEDURE: Biopsy, DEVICE: Intraperitoneal Chemotherapy, DRUG: Mitomycin
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Megestrol Acetate, BIOLOGICAL: Pterostilbene
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Supportive Care, OTHER: Quality-of-Life Assessment